SP Plus (NASDAQ:SP) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.67 by 37.31 percent. This is a 14.29 percent decrease over earnings of $0.49 per share from the same period last year.
HCW Biologics Enters CRADA With National Cancer Institute
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span
